So-Young to Report Third Quarter 2022 Financial Results on November 18, 2022
BEIJING, Nov. 11, 2022 /PRNewswire/ -- So-Young International Inc. (NASDAQ: SY) ("So-Young" or the "Company"), the largest and most vibrant social community in China for consumers, professionals and service providers in the medical aesthetics industry, today announced that it will report its financial results for the third quarter ended September 30, 2022, before U.S. markets open on November 18,...
Winning the Fight Against Neuropathy in Diabetic Patients
P&G Health and medical experts share clinical guidance in the diagnosis and treatment of nerve damage among diabetic patients MANILA, Philippines, Nov. 11, 2022 /PRNewswire/ -- Ahead of World Diabetes Day 2022, P&G Health, brought together globally renowned multidisciplinary medical experts with Healthcare Professionals from across Asia-Pacific and the Middle East, at the 'Winning the Fight Against Neuropathy in...
LOTUS REPORTS ITS BEST QUARTER EVER WITH THE BIGGEST LAUNCH IN ITS HISTORY
TAIPEI, Taiwan, Nov. 11, 2022 /PRNewswire/ -- Lotus Pharmaceutical (1795: TT), a multinational pharmaceutical company, today reported its financial results for the third quarter ended 30 September 2022. New building Third quarter financial highlights: Third quarter 2022 is the best quarter ever in the Company's history, majorly driven by the successful launch of Lenalidomide...
Frost & Sullivan Institute recognizes Exemplary Companies winning the Enlightened Growth Leadership Awards for the Second time
SANTA CLARA, Calif., Nov. 11, 2022 /PRNewswire/ -- Frost & Sullivan Institute's Enlightened Growth Leadership Best Practices Recognition lauds organizations around the globe that are committed to 'growth for good'. There exists an obsolete pressure of maintaining a tradeoff between business growth and global priorities, but the Frost & Sullivan Institute has identified global Companies that pursue growth and transformation...
Mindray Ultrasound Launches Multicenter Research for SEA Regions
BALI, Indonesia, Nov. 11, 2022 /PRNewswire/ -- Themed "Building Bridges, Connecting Visions", Mindray successfully held the 2022 SEA & SA Mindray Ultrasound Forum in Bali, Indonesia. More than 150 participants from Indonesia, the Philippines, and Thailand joined the academic forum where experts exchange clinical expertise and share insights on industry-leading technologies. At the opening ceremony of the forum, Mindray officially launched the multicenter...
CHOCOLATE TOUCH®, NEXT-GENERATION DRUG-COATED ANGIOPLASTY BALLOON FOR THE TREATMENT OF PERIPHERAL ARTERIAL DISEASE RECEIVES FDA APPROVAL
SINGAPORE, Nov. 11, 2022 /PRNewswire/ -- Genesis MedTech Group announced today that the Food and Drug Administration (FDA) has approved the Chocolate Touch® Drug-coated Balloon PTA Catheter, developed by TriReme Medical LLC, for the treatment of patients with peripheral artery disease in the superficial femoral artery and the popliteal artery. The Chocolate Touch® drug-coated balloon (DCB) was shown to...
The new THREAD LIFT with approved design patent “TIMEMACHINE LIFT THREAD, ANCHORING DUAL COG”
SEOUL, South Korea, Nov. 11, 2022 /PRNewswire/ -- Safe thread lifting without surgery, the most representative lifting method with various advantages TIMEMACHINE LIFE THREAD Recently, with the development of various lifting procedures, there are many methods to perfect a natural look, and many people are getting these procedures regularly due to lower cost. The most popular lifting procedure...
The new THREAD LIFT with approved design patent “TIMEMACHINE LIFT THREAD, ANCHORING DUAL COG”
SEOUL, South Korea, Nov. 11, 2022 /PRNewswire/ -- Safe thread lifting without surgery, the most representative lifting method with various advantages TIMEMACHINE LIFE THREAD Recently, with the development of various lifting procedures, there are many methods to perfect a natural look, and many people are getting these procedures regularly due to lower cost. The most popular lifting procedure...
J INTS BIO, Novel Oral 4th Generation EGFR TKI ‘JIN-A02’ – Phase 1/2 IND approved by US FDA
- First patient expected in December 2022 SEOUL, South Korea, Nov. 11, 2022 /PRNewswire/ -- J INTS BIO announced on November 9th that it had received approval from the US FDA for its Phase 1/2 clinical trial of its Novel Oral 4th Generation EGFR TKI 'JIN-A02' in patients with advanced non-small cell lung cancer (NSCLC). ...
Bridgewest Group inks deal with Pfizer to acquire injectable manufacturing plant in Western Australia
MIAMI and PERTH, Australia, Nov. 11, 2022 /PRNewswire/ -- Global private investment firm, Bridgewest Group, recognized for developing innovative companies in life sciences, software, and deep tech, is expanding its portfolio. Today, Bridgewest Group has announced the signing of a definitive agreement to purchase the sterile injectable manufacturing facility of Pfizer (Perth)...
